Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Terminated Phase 1 Trials for Lenalidomide (DB00480)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0030487 (Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma) | Terminated | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01045928 | Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma | Treatment |